Salt Lake Business Journal
  • Home
  • News
  • People
    • People On The Move
    • Submit To People On The Move
  • Calendar
    • View Events
    • Add An Event
  • Digital Editions
    • Salt Lake Business Journal 2025
    • Salt Lake Business Journal 2024
    • Enterprise 2023
    • Enterprise 2022
    • Enterprise 2021
    • Enterprise 2020
    • Enterprise 2019
    • Enterprise 2018
    • Enterprise 2017
    • Enterprise 2016
    • Enterprise 2015
    • Enterprise 2014
    • Enterprise 2013
    • Enterprise 2012
    • Enterprise 2011
  • Caritas Quarterly
  • ELM
  • Contact/About
    • Contact Information
    • Contact General & Subscriptions
    • Contact About Editorial
    • Contact About Advertising
    • About Us
  • Subscribe
    • Subscription Options
    • Give A Gift Subscription
    • Subscribe To Our Email Newsletter
  • Log In/Out

Tom Parks

Q Therapeutics Inc., Salt Lake City, has appointed Tom Parks as an independent member of the company’s board of directors. Parks also has agreed to serve on the board's Nominating and Governance Committee. Parks has more than 30 years of experience in life science research and its translation into therapeutic products. He began work as a faculty member in the Department of Neurobiology & Anatomy at the University of Utah School of Medicine in 1978, including serving as chair of the department from 1992-2007. He was a co-founder of NPS Pharmaceuticals Inc. and served on its board from 1986-2006. From 2008-2016, Parks was vice president for research and president of the Research Foundation for the University of Utah. He currently serves on the boards of Navigen Pharmaceuticals Inc., SentrX Animal Care Inc. and ConusRx Inc.
  • 137.jpg

Listing Details

« Previous listing in People On The Move | Next listing in People On The Move »

Suntec Azre ad

eccles ad

UMB Bank ad

Cottonwood Title ad

Umpqua Bank Ad

golf stonebridge utah

Canyon View Credit Union

Login/Out

  • Forgot your password?
  • Forgot your username?

Contact Us | 801-254-5974 | News | Events | Newsletter | © Salt Lake Business Journal